---
title: "STERIS plc (STE.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/STE.US.md"
symbol: "STE.US"
name: "STERIS plc"
industry: "Health Care Equipment"
datetime: "2026-05-19T20:16:54.709Z"
locales:
  - [en](https://longbridge.com/en/quote/STE.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/STE.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/STE.US.md)
---

# STERIS plc (STE.US)

## Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.steris.com](https://www.steris.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:13.000Z

**Overall: B (0.34)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 11 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.73% |  |
| Net Profit YoY | 27.28% |  |
| P/B Ratio | 2.90 |  |
| Dividend Ratio | 1.16% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 20877230571.75 |  |
| Revenue | 5935900000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 11.34% | B |
| Profit Margin | 13.18% | B |
| Gross Margin | 44.28% | B |
| Revenue YoY | 8.73% | B |
| Net Profit YoY | 27.28% | B |
| Total Assets YoY | 5.82% | C |
| Net Assets YoY | 8.79% | B |
| Cash Flow Margin | 171.47% | B |
| OCF YoY | 8.73% | B |
| Turnover | 0.57 | C |
| Gearing Ratio | 32.97% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - STERIS plc",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.73%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "27.28%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.90",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.16%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "20877230571.75",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "5935900000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "11.34%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "13.18%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "44.28%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "8.73%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "27.28%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "5.82%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.79%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "171.47%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "8.73%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.57",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "32.97%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 26.69 | 28/183 | 37.86 | 36.69 | 33.05 |
| PB | 2.90 | 74/183 | 3.61 | 3.47 | 3.16 |
| PS (TTM) | 3.52 | 80/183 | 4.42 | 4.29 | 3.91 |
| Dividend Yield | 1.16% | 13/183 | 1.09% | 0.96% | 0.92% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T04:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 38% |
| Overweight | 3 | 38% |
| Hold | 2 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 214.42 |
| Highest Target | 300.00 |
| Lowest Target | 231.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/STE.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/STE.US/norm.md)
- [Related News](https://longbridge.com/en/quote/STE.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/STE.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**